Literature DB >> 2322317

Characterization of endopeptidase 3.4.24.11 ("enkephalinase") activity in human plasma and cerebrospinal fluid.

M G Spillantini1, F Sicuteri, S Salmon, B Malfroy.   

Abstract

The presence of the neutral metallo-endopeptidase 3.4.24.11 ("enkephalinase") activity was investigated by fluorimetric assay in human body fluids. Although the enzyme was previously known to occur exclusively in membrane bound form in the human or animal central nervous system, its activity was detected in human cerebrospinal fluid (CSF), plasma and amniotic fluid. Although the endopeptidase 3.4.24.11 activity found in human body fluids has properties closely related to the membrane bound enzyme such as affinity constant for the inhibitors, optimal pH and Km for the substrate, the Vmax values were in CSF, plasma and amniotic fluid, respectively, 2 x 10(3), 10(2), 10 lower than mouse brain homogenate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2322317     DOI: 10.1016/0006-2952(90)90012-a

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  18 in total

1.  ARNIs: balancing "the good and the bad" of neuroendocrine response to HF.

Authors:  Roberto Ferrari; J Cardoso; M C Fonseca; C Aguiar; J I Moreira; A Fucili; C Rapezzi
Journal:  Clin Res Cardiol       Date:  2019-09-17       Impact factor: 5.460

2.  Cell-specific activity of neprilysin 2 isoforms and enzymic specificity compared with neprilysin.

Authors:  Christiane Rose; Stéphanie Voisin; Claude Gros; Jean-Charles Schwartz; Tanja Ouimet
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

Review 3.  Racecadotril versus loperamide: antidiarrheal research revisited.

Authors:  S Huighebaert; F Awouters; G N J Tytgat
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

4.  In vitro and in vivo degradation of Abeta peptide by peptidases coupled to erythrocytes.

Authors:  Yinxing Liu; Hanjun Guan; Tina L Beckett; Maria Aparecida Juliano; Luiz Juliano; Eun Suk Song; K Martin Chow; M Paul Murphy; Louis B Hersh
Journal:  Peptides       Date:  2007-09-29       Impact factor: 3.750

5.  Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation?

Authors:  M Matucci-Cerinic; A Lombardi; G Leoncini; A Pignone; L Sacerdoti; M G Spillantini; G Partsch
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

6.  Neutral endopeptidase activity is not elevated in serum in children with cholestatic liver disease: a unique role of aminopeptidase-m in sequential hydrolysis of peptides.

Authors:  Roman M Janas; Jerzy Socha; Jadwiga Janas; Krzysztof Warnawin
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

7.  Neprilysin, obesity and the metabolic syndrome.

Authors:  K F Standeven; K Hess; A M Carter; G I Rice; P A Cordell; A J Balmforth; B Lu; D J Scott; A J Turner; N M Hooper; P J Grant
Journal:  Int J Obes (Lond)       Date:  2010-11-02       Impact factor: 5.095

8.  Pharmacologic Comparison of Clinical Neutral Endopeptidase Inhibitors in a Rat Model of Acute Secretory Diarrhea.

Authors:  David W Griggs; Michael J Prinsen; Jonathan Oliva; Mary A Campbell; Stacy D Arnett; Deena Tajfirouz; Peter G Ruminski; Ying Yu; Brian R Bond; Yuhua Ji; Georg Neckermann; Robert K M Choy; Eugenio de Hostos; Marvin J Meyers
Journal:  J Pharmacol Exp Ther       Date:  2016-02-23       Impact factor: 4.030

9.  Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders.

Authors:  Michela Deleidi; Walter Maetzler
Journal:  Int J Alzheimers Dis       Date:  2012-10-22

10.  Angiotensin-converting enzyme and enkephalinase in human breast cyst fluid.

Authors:  K L Frame; K Patton; M J Reed; M W Ghilchik; D C Parish
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.